Sin embargo, su acceso ms amplio podra traer riesgos significativos, especialmente con la proliferacin de genricos no regulados
However, there is also considerable data for other solid cancers, suggesting a potential role in reducing cell proliferation and invasiveness, modulating gene expression, repairing DNA damage, and possibly sensitizing to systemic therapies (3745)
A multiplexed HILIC-MS/HRMS assay for the assessment of transporter Inhibition biomarkers in phase I clinical trials: Isobutyryl-Carnitine as an organic cation transporter (OCT1) biomarker
& Bentley, W
It is not intended to diagnose, treat, cure, or prevent any condition
Its going to be up to the physicians to determine what is appropriate care for their patients, but we think Bydureon is very good, Jim McDermott, AstraZenecas Medical Affairs lead for diabetes, said last month.